https://www.selleckchem.com/pr....oducts/emd-1214063.h
1% vs. 7.0%), than those without diabetes. Higher levels of leukocytes ( 5.37 × 10 /L), older age, and comorbid cerebrovascular disease and chronic renal disease independently contributed to in-hospital death of patients with COVID-19 and diabetes. Leukocytes 5.37 × 10 /L and the application of immunoglobulin were associated with shorter survival duration and lower mortality, respectively, in critical patients with COVID-19 and diabetes. More attention should be paid to patients with COVID-19 and diabetes, especially when t
Like
Comment
Share
